RecruitingNCT04888936

Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies


Sponsor

National Cancer Institute (NCI)

Enrollment

500 participants

Start Date

Apr 25, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Background: RASopathies are a group of conditions caused by a genetic change. People with a RASopathy may have developmental issues, cognitive disability, poor growth, and birth defects. They may also have an increased risk for developing cancer. Researchers want to learn more. Objective: To learn more about RASopathies, how genes and environmental factors contribute to cancer development in people with RASopathies, and the best way to find these cancers and other conditions early or prevent them. Eligibility: People of any age who have or may have a RASopathy, and their family members. Design: Participants will complete questionnaires about their personal and family medical history. Their medical records will be reviewed. Participants will give blood and urine samples. They will give a saliva or cheek cell sample. Some samples will be used for genetic testing. Participants may have a skin biopsy. Participants may have a physical exam by the RASopathies study team. They may also have exams by additional specialists, such as dentists; urologists; ear, nose, and throat doctors; and neurologists. Participants may have computed tomography of the face and mouth. They may have an ultrasound of the abdomen. They may have a bone density scan. They may have skeletal and/or spine x-rays. They may have magnetic resonance imaging of the brain, low back, chest, and/or heart. They may be photographed. Participants may have other tests, such as sleep, brain and heart electrical activity, speech and swallow, metabolism, hearing, eye, and colon function tests. Participants may sign separate consent forms for some tests. Participation will last indefinitely. Participants may be contacted once in a while by phone or mail. They may have follow-up visits.


Eligibility

Min Age: 1 MonthMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This study at the NIH is following people and families affected by RASopathies — a group of rare genetic conditions caused by mutations in the RAS signaling pathway. This group includes Noonan syndrome, Costello syndrome, Cardiofaciocutaneous syndrome, Legius syndrome, and others. Researchers are studying how these conditions affect people throughout their lives, what treatments work, and whether there are new genetic variants yet to be discovered. You may be eligible if: - You have a clinical or genetic diagnosis of a RASopathy (any of the above conditions) - You carry a genetic variant (pathogenic or uncertain significance) in a RASopathy-related gene - You are a family member or caregiver of someone with a RASopathy (as a control participant) - There is no age restriction You may NOT be eligible if: - You have only a diagnosis of NF1 (neurofibromatosis type 1) without another RASopathy diagnosis - You are unable to return for follow-up visits (for the NIH Clinical Center cohort) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

National Cancer Institute - Shady Grove

Rockville, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04888936


Related Trials